retatrutide approval status october 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA ends semaglutide shortage, closing

Retatrutide binds to three receptors instead of just one or two

Streaks reward consistency instead of perfection

This progress in scientific development enables a 1-week administration of the drug, making them an efficient alternative to other antidiabetic drugs, such as metformin, which requires two daily doses, and the updated metformin, which requires daily doses [100, 101]

the app has a 4.8-star App Store rating across 25K ratings and is available on iPhone and Android

At 48 weeks, the least-squares mean percentage change in body weight in the retatrutide groups was -8.7% (1 mg), -17.1% (combined 4 mg), -22.8% (combined 8 mg), and an astounding -24.2% (12 mg), compared to -2.1% in the placebo group

Can Retatrutide treat type 2 diabetes